There are a handful of stocks out there that the market loves and should take even higher by the end of the year, CNBC's Jim Cramer said Thursday.
If you’re a football fan as well as a stock investor, Cramer says, you’re in luck.
The Mad Money host says it's time to think about putting money to work. “Let me give you the list I have been working off of,” Cramer said.
Aug 26- Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential.
If you’re a bull Cramer’s got news. Profiting from this market could get a lot harder.
Looking to buy? Cramer doesn’t want you to make a move before asking yourself this.
Biotech stocks are some of the best-performing S&P stocks this month. Chris Raymond, senior biotech analyst at Robert W. Baird, shares his top picks.
Huge earnings are coming in the week ahead. Companies including Apple, McDonald’s and Boeing all report. Are you ready?
July 18- Celgene Corp said it will stop a late-stage trial of its blood cancer drug Revlimid after it observed a higher number of deaths in patients taking the drug compared to those on another treatment. Celgene shares were down 2 percent to $134 in premarket trading.
Some of the names on the move ahead of the open.
July 18- Celgene Corp said it will stop a late-stage trial of its blood cancer drug Revlimid after it observed a higher number of deaths in patients taking the drug compared to those on a placebo. The trial was placed on a clinical hold by the U.S. Food and Drug Administration on July 12, Celgene said.
Pharmaceutical and biotech stocks have outperformed markets this year, and with J&J's second-quarter earnings beat, investors may hope earnings will push stocks even higher.
NEW YORK, July 11- The S&P 500 index and the Dow industrials closed on Thursday at record highs, a day after Federal Reserve Chairman Ben Bernanke said the U.S. central bank will keep a loose monetary policy for some time to lower the unemployment rate.
NEW YORK, July 11- U.S. stocks rallied on Thursday, boosting the S&P 500 above its record closing high, a day after Federal Reserve Chairman Ben Bernanke reasserted that monetary policy will remain accommodative for some time.
*Advanced Micro Devices Inc jumps after upgrade. NEW YORK, July 11- U.S. stocks jumped on Thursday, with the S&P 500 index climbing above its all-time closing high, after Federal Reserve Chairman Ben Bernanke reasserted that monetary policy will remain accommodative for some time.
NEW YORK, July 11- U.S. stocks jumped on Thursday, putting the S&P 500 within range of an all-time closing high, after Federal Reserve Chairman Ben Bernanke once again said monetary policy will remain "accommodative" for some time.
*Costco June sales top expectations. NEW YORK, July 11- U.S. stocks jumped on Thursday, with each of the major indexes gaining 1 percent, after comments by U.S. "His statement that they will be highly accommodative for the foreseeable future is pretty clear and the market loved it," said Doug Cote, chief market strategist at ING U.S. Investment Management in New York.
The delay of Obamacare's employer mandate isn't a blow to health-care stocks. However, the outlook for reform is another matter.
The trick to successful investing is knowing when to take profits and walk away. In this case, Cramer says it’s time.
Amgen's low-ball offer to Onyx Pharmaceuticals has set off speculation of a potential bidding war that could leave another company walking away with Onyx.